About Klinikum Klagenfurt am Wörthersee
Das Klinikum Klagenfurt am Wörthersee, ehemals Landeskrankenhaus Klagenfurt – LKH, ist ein Krankenhaus der Maximalversorgung in der Kärntner Landeshauptstadt Klagenfurt am Wörthersee. Träger ist die Kärntner Landeskrankenanstalten-Betriebsgesellschaft.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
4
Celgene
4
Klinikum Klagenfurt am Wörthersee
4
Medical University of Graz
4
Amgen
3
Shire
3
Abbott Medical Devices
2
Abivax S.A.
2
BeiGene
2
C. R. Bard
2
Landeskrankenanstalten-Betriebsgesellschaft
2
Clinical Trials at Klinikum Klagenfurt am Wörthersee
During the past decade, Klinikum Klagenfurt am Wörthersee conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 16 clinical trials were completed, i.e. on
average, 34.8% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 11 clinical trials were completed. i.e. 68.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries
2005-03-01
2009-10-01
Completed
120
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
2001-05-01
2009-09-01
Completed
120
Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer
2005-09-01
Completed
835
A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13
2006-01-01
2013-03-01
Completed
683
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
2000-07-01
2012-01-01
Completed
4,559
A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System
2007-05-01
2010-02-01
Completed
104
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinikum Klagenfurt am Wörthersee" #1 sponsor was "Bayer" with 4 trials, followed by "Celgene" with 4 trials
sponsored, "Klinikum Klagenfurt am Wörthersee" with 4 trials sponsored, "Medical University of Graz" with 4 trials sponsored and "Amgen"
with 4 trials sponsored. Other sponsors include 44 different institutions and
companies that sponsored additional 47 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Klagenfurt am Wörthersee"
#1 collaborator was "Klinikum Klagenfurt am Wörthersee" with 5 trials as a collaborator, "Medical University of Vienna" with 3 trials as a collaborator, "European Commission" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator and "Johannes Kepler University of Linz" with 2 trials as a collaborator. Other collaborators include 38 different institutions and companies that were
collaborators in the rest 43 trials.
Clinical Trials Conditions at Klinikum Klagenfurt am Wörthersee
According to Clinical.Site data, the most researched conditions in "Klinikum Klagenfurt am Wörthersee" are
"Ulcerative Colitis" (6 trials), "Acute Myocardial Infarction" (3 trials), "Atherosclerosis" (2 trials), "Crohn Disease" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Klinikum Klagenfurt am Wörthersee" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Klagenfurt am Wörthersee
Most popular intervention types in "Klinikum Klagenfurt am Wörthersee" are "Drug" (43 trials), "Device" (11 trials), "Other" (9 trials), "Procedure" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (17 trials), "Brigatinib" (2 trials), "GED-0301" (2 trials), "Gemcitabine" (2 trials) and "Ontamalimab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Klagenfurt am Wörthersee
The vast majority of trials in "Klinikum Klagenfurt am Wörthersee" are
62 trials for "All" genders and 6 trials for "Female" genders.
Clinical Trials Status at Klinikum Klagenfurt am Wörthersee
Currently, there are NaN active trials in "Klinikum Klagenfurt am Wörthersee".
undefined are not yet recruiting,
11 are recruiting,
14 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 33 completed trials in Klinikum Klagenfurt am Wörthersee,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Klagenfurt am Wörthersee, 0 "Phase 1"
clinical trials were conducted, 16 "Phase 2" clinical
trials and 24 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 15 trials that are defined as “Not Applicable".
Departments of Klinikum Klagenfurt am Wörthersee
Klinikum Klagenfurt am Wörthersee has several departments that took part in Clinical trials: "Klinikum Klagenfurt am Wörthersee; 2. Medizinische Abteilung" - 2 trials
Departments List
Name
City
Trials